Abstract
Therapeutics targeting sphingosine-1-phosphate (S1P), a kind of lipid mediator regulating immune cell trafficking, has been emerging rapidly as a novel line of regimen for autoimmune diseases, including rheumatoid arthritis (RA). Here, we propose that S1P-targeted therapy is beneficial not only for limiting inflammation but for preventing bone-resorptive disorders, such as osteoporosis, by controlling the migratory behavior of osteoclast precursors and therefore would be good for treating elderly female RA patients who suffer from postmenopausal osteoporosis and arthritis simultaneously.
This is a preview of subscription content, log in via an institution to check access.
References
Van Volenhoven RF (2009) Treatment of rheumatoid arthritis: state of the art 2009. Nat Rev Rheumatol 5:531–541
Rosen H, Sphingosine Goetzl EJ (2005) 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5:560–570
Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V et al (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355–360
Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J et al (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296:346–349
Kappos L, Antel J, Comi G, Montalban X, O’Connor P, Polman CH et al (2006) on behalf of the FTY720 D2201 Study Group. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 355:1124–1140
Japtok L, Kleuser B (2009) The role of sphingosine-1-phosphate receptor modulators in the prevention of transplant rejection, autoimmune diseases. Curr Opin Investig Drugs 10:1183–1194
Ishii M, Egen JG, Klauschen F, Meier-Schellersheim M, Saeki Y, Vacher J et al (2009) Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458:524–528
Klauschen F, Ishii M, Qi H, Bajénoff M, Egen JG, Germain RN et al (2009) Quantifying cellular interaction dynamics in 3D fluorescence microscopy data. Nat Protoc 4:1305–1311
Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM (1992) Induction of arthritis with monoclonal antibodies to collagen. J Immunol 148:2103–2108
Sasai M, Saeki Y, Ohshima S, Nishioka K, Mima T, Tanaka T et al (1999) Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum 42:1635–1643
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kikuta, J., Iwai, K., Saeki, Y. et al. S1P-targeted therapy for elderly rheumatoid arthritis patients with osteoporosis. Rheumatol Int 31, 967–969 (2011). https://doi.org/10.1007/s00296-010-1634-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1634-8